Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Self-reports of executive functioning in multiple sclerosis: to trust or not to trust.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice.
Functional impairments in white matter syndrome of neuropsychiatric systemic lupus erythematosus are similar to those observed in patients with multiple sclerosis.
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Menopause in multiple sclerosis: therapeutic considerations.
Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
[Brain metabolism in multiple sclerosis: effects of neurotrophic therapy.]
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Multiple sclerosis: Disease activity is reduced in CIS after BCG vaccination.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Pharmacological treatments for fatigue associated with palliative care.
Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.
Mesenchymal stem cells: A new diagnostic tool?
Emerging stem cell therapies: treatment, safety, and biology.
The feasibility and short-term benefits of Blue Prescription: a novel intervention to enable physical activity for people with multiple sclerosis.
Midkine and multiple sclerosis.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.

Pages